Zobrazeno 1 - 10
of 1 148
pro vyhledávání: '"Fastenau, J."'
Autor:
Nguyen A; Division of Urology, Department of Surgery, Rutgers New Jersey Medical School, Newark, NJ. Electronic address: anhtnguyen732@gmail.com., Fastenau J; New Jersey Medical School, Newark, NJ., Mehta J; New Jersey Medical School, Newark, NJ., Kovac E; Division of Urology, Department of Surgery, Rutgers New Jersey Medical School, Newark, NJ; Cancer Institute of New Jersey, Newark, NJ., Weiss RE; Division of Urology, Department of Surgery, Rutgers New Jersey Medical School, Newark, NJ; Cancer Institute of New Jersey, Newark, NJ.
Publikováno v:
Clinical genitourinary cancer [Clin Genitourin Cancer] 2024 Dec; Vol. 22 (6), pp. 102178. Date of Electronic Publication: 2024 Aug 03.
Autor:
Barsdorf AI; Clinical Outcomes Solutions, Chicago, IL, USA., Fastenau J; Janssen Global Services, LLC, a Johnson & Johnson Company, Raritan, NJ, USA., Lee S; FingerPost Consulting, Cheshire, UK., Li X; Bristol Myers Squibb, Lawrenceville, NJ, USA., O'Brien E; Janssen Global Services, LLC, a Johnson & Johnson Company, Horsham, PA, USA., Stevenson B; Clinical Outcomes Solutions, Chicago, IL, USA., Becker B; Bristol Myers Squibb, Lawrenceville, NJ, USA. brandon.becker@bms.com.
Publikováno v:
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation [Qual Life Res] 2024 Nov 22. Date of Electronic Publication: 2024 Nov 22.
Publikováno v:
Diabetes, Metabolic Syndrome and Obesity, Vol Volume 13, Pp 2049-2055 (2020)
Heather Rozjabek,1 John Fastenau,1 Anne LaPrade,2 Nikoletta Sternbach2 1Janssen Global Services, Raritan, NJ, USA; 2Kantar, New York, NY, USACorrespondence: John FastenauJanssen Global Services, LLC, 700 US-202, Raritan, NJ 08869, USATel +1 908 429 1
Externí odkaz:
https://doaj.org/article/e6551e94cb1b49d6bcc5c06d27b8d0ac
Autor:
Martin TG; University of California San Francisco, San Francisco, CA. Electronic address: Tom.Martin@ucsf.edu., Moreau P; Hematology Clinic, University Hospital Hôtel-Dieu, Nantes, France., Usmani SZ; Levine Cancer Institute/Atrium Health, Charlotte, NC., Garfall A; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Mateos MV; University Hospital of Salamanca/IBSAL/CIC/CIBERONC, Salamanca, Spain., San-Miguel JF; Clínica Universidad de Navarra (CCUN), CIMA, CIBERONC, IDISNA, Pamplona, Spain., Oriol A; Institut Català d'Oncologia and Institut Josep Carreras, Hospital Germans Trias i Pujol, Badalona, Barcelona, Spain., Nooka AK; Winship Cancer Institute, Emory University, Atlanta, GA., Rosinol L; Hospital Clínic, IDIBAPS, University of Barcelona, Barcelona, Spain., Chari A; Mount Sinai School of Medicine, New York, NY., Karlin L; Service d'Hématologie Clinique, Centre Hospitalier Lyon Sud, Pierre-Bénite, France., Krishnan A; City of Hope Comprehensive Cancer Center, Duarte, CA., Bahlis N; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, AB, Canada., Popat R; University College London Hospitals, NHS Foundation Trust, London, UK., Besemer B; University of Tuebingen, Tuebingen, Germany., Martínez-López J; Haematological Malignancies Clinical Research Unit, Hospital 12 de Octubre Universidad Complutense, CNIO, CIBERONC, Madrid, Spain., Delforge M; Universitaire Ziekenhuizen Leuven, Leuven, Belgium., Trancucci D; Janssen Research & Development, Raritan, NJ., Pei L; Janssen Research & Development, Raritan, NJ., Kobos R; Janssen Research & Development, Raritan, NJ., Fastenau J; Janssen Research & Development, Raritan, NJ., Gries KS; Janssen Research & Development, Raritan, NJ., van de Donk NWCJ; Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
Publikováno v:
Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2024 Mar; Vol. 24 (3), pp. 194-202. Date of Electronic Publication: 2023 Nov 14.
Publikováno v:
Journal of Applied Physics; 1/7/2021, Vol. 129 Issue 1, p1-7, 7p
Autor:
Davis S; Janssen Global Services, LLC, Horsham, PA, USA. sdavis26@its.jnj.com., Edwards T; RTI Health Solutions, Research Triangle Park, NC, USA., Norcross L; RTI Health Solutions, Research Triangle Park, NC, USA., Fehnel S; RTI Health Solutions, Research Triangle Park, NC, USA., Beaudet A; Actelion Pharmaceuticals Ltd, a Janssen Pharmaceutical Company of Johnson & Johnson, Allschwil, Switzerland., Eckart M; Actelion Pharmaceuticals Ltd, a Janssen Pharmaceutical Company of Johnson & Johnson, Allschwil, Switzerland., Fastenau J; Janssen Global Services, LLC, Horsham, PA, USA.
Publikováno v:
Journal of patient-reported outcomes [J Patient Rep Outcomes] 2023 Dec 18; Vol. 7 (1), pp. 134. Date of Electronic Publication: 2023 Dec 18.
In the phase 3 ANDROMEDA trial, patients treated with daratumumab, bortezomib, cyclophosphamide, and dexamethasone (D-VCd) had significantly higher rates of organ and hematologic response compared with patients who received VCd alone. Here, we presen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::63281bbd680a2988a56e25f81c47cf81
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3220417
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3220417
Autor:
Wyrwich, KW, Clark, A, Fastenau, J, O'Brien, E, Kang, A, Gaitonde, P, Chan, EKH, Becker, B, Martin, M
Publikováno v:
In Value in Health June 2024 27(6) Supplement:S317-S317
Review of Active Surveillance in Underrepresented and High-Risk Populations: Feasibility and Safety.
Autor:
Fastenau J; Division of Urology, Department of Surgery, Rutgers New Jersey Medical School, 140 Bergen Street, Room G1680, Newark, NJ, 07103, USA., Jain K; Division of Urology, Department of Surgery, Rutgers New Jersey Medical School, 140 Bergen Street, Room G1680, Newark, NJ, 07103, USA., Popovic A; Division of Urology, Department of Surgery, Rutgers New Jersey Medical School, 140 Bergen Street, Room G1680, Newark, NJ, 07103, USA., Kovac E; Division of Urology, Department of Surgery, Rutgers New Jersey Medical School, 140 Bergen Street, Room G1680, Newark, NJ, 07103, USA. ek752@njms.rutgers.edu.; Cancer Institute of New Jersey, Newark, NJ, USA. ek752@njms.rutgers.edu.
Publikováno v:
Current urology reports [Curr Urol Rep] 2023 Jul; Vol. 24 (7), pp. 307-315. Date of Electronic Publication: 2023 Mar 30.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.